Seeking Alpha

AVNR
  Avanir Pharmaceuticals, Inc - NASDAQ

11/27/2014, 6:54 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
AVNR vs. ETF Alternatives
Company Description
Avanir Pharmaceuticals is a biopharmaceutical company engaged in acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders.